Mannkind Corp (MNKD) Expected Move

Tracking the MNKD expected move helps you see how far Mannkind Corp's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Mannkind Corp's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the MNKD expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For MNKD, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The MNKD expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Mannkind Corp is unlikely to go.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions.

MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the MNKD expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Mannkind Corp expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about MNKD.